Back to search
FDAFDA · Food and drugs·Recall number Z-0620-2019

ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

Published December 26, 2018 · Recall initiated: November 1, 2018

Summary

FDA records medical device Class II recall Z-0620-2019, published December 26, 2018 and initiated November 1, 2018. Recalling firm: Clark Laboratories, Inc. (dba,Trinity Biotech USA); Status: Terminated; Reported quantity: 14 devices; Lot: all serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

lack of 510K

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Distributor
IL, WV, NJ, AZ, MD, UT
Lot
all serial numbers
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only. recalled?

Yes. FDA published recall Z-0620-2019 on December 26, 2018. Reported hazard: lack of 510K

What should I do if I have this product?

Voluntary: Firm initiated · Letter